Jazz Pharmaceuticals PLC (JAZZ)
Fixed asset turnover
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (ttm) | US$ in thousands | 3,809,836 | 3,720,411 | 3,685,651 | 3,662,251 | 3,569,427 | 3,471,828 | 3,371,195 | 3,194,350 | 2,999,693 | 2,864,101 | 2,628,980 | 2,436,329 | 2,361,556 | 2,277,779 | 2,214,357 | 2,184,676 | 2,158,500 | 2,053,217 | 1,985,763 | 1,953,884 |
Property, plant and equipment | US$ in thousands | 165,196 | 222,476 | 229,264 | 227,552 | 223,379 | 216,339 | 239,523 | 257,632 | 251,099 | 249,153 | 271,581 | 123,863 | 127,935 | 128,204 | 128,259 | 129,562 | 131,506 | 129,472 | 127,183 | 113,006 |
Fixed asset turnover | 23.06 | 16.72 | 16.08 | 16.09 | 15.98 | 16.05 | 14.07 | 12.40 | 11.95 | 11.50 | 9.68 | 19.67 | 18.46 | 17.77 | 17.26 | 16.86 | 16.41 | 15.86 | 15.61 | 17.29 |
December 31, 2023 calculation
Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $3,809,836K ÷ $165,196K
= 23.06
Fixed asset turnover is a key financial ratio that indicates how efficiently a company is utilizing its fixed assets to generate revenue. By analyzing the data provided for Jazz Pharmaceuticals plc over the past eight quarters, we observe fluctuations in the fixed asset turnover ratio.
In Q4 2023, Jazz Pharmaceuticals achieved a fixed asset turnover ratio of 22.60, indicating that the company generated $22.60 in revenue for every dollar invested in fixed assets during that quarter. This represents a significant increase compared to the previous quarter (Q3 2023), where the ratio stood at 17.06. The substantial jump in fixed asset turnover suggests improved efficiency in utilizing fixed assets to drive revenue growth.
Looking at the trend over the eight quarters, Jazz Pharmaceuticals has shown fluctuations in its fixed asset turnover ratio, with periods of both growth and decline. The company experienced a peak in Q4 2023, demonstrating a strong ability to generate revenue relative to its investment in fixed assets. However, it is important to note that fixed asset turnover ratios alone may not provide a complete picture, and further analysis of other financial metrics is recommended for a comprehensive assessment of the company's overall financial performance.
Peer comparison
Dec 31, 2023